D-1513-2016 Class II Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-1513-2016 was initiated by Sandoz Inc on Aug 24, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised. The recall status is terminated (terminated Jul 12, 2017). Affected quantity: 32,099 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 28, 2016
Initiation Date
Aug 24, 2016
Termination Date
Jul 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,099 cartons

Product description

Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Reason for recall

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 080514, 080614, 081114, 081214, 081314, 081414, 082714, 082814, 082914, Exp 08/16; 090214, 090314, 090814, 090914, 091014, 091114, 091214, 091514, Exp 09/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1513-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1513-2016. Report a data issue: hello@regdatalab.com.